Disease · MONDO_0002508
Comparisons in its trials18
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 18 of 18
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Stannous Fluoride vs Sodium Monofluorophosphate: serious adverse events | 0 of 125 | 0 of 128 | 253 | NCT02750943 | Trial comparisons |
| Sodium Bicarbonate Dentrifice vs 0% Sodium Bicarbonate Dentrifice: serious adverse events | 0 of 124 | 0 of 123 | 247 | NCT02207907 | Trial comparisons |
| Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice: serious adverse events | 0 of 123 | 0 of 123 | 246 | NCT02207400 | Trial comparisons |
| Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): deaths from any cause | 0 of 94 | 0 of 96 | 190 | NCT05654662 | Trial comparisons |
| Test Product (Corsodyl Original Toothpaste) vs Reference Product (Colgate Cavity Protection Toothpaste): serious adverse events | 0 of 94 | 0 of 96 | 190 | NCT05654662 | Trial comparisons |
| Test Toothpaste vs Reference Toothpaste (Negative Control): deaths from any cause | 0 of 78 | 0 of 83 | 161 | NCT06602466 | Trial comparisons |
| Test Toothpaste vs Reference Toothpaste (Negative Control): serious adverse events | 0 of 78 | 0 of 83 | 161 | NCT06602466 | Trial comparisons |
| Test Product vs Reference Product (Negative Control): deaths from any cause | 0 of 76 | 0 of 76 | 152 | NCT06143670 | Trial comparisons |
| Test Product vs Reference Product (Negative Control): serious adverse events | 0 of 76 | 0 of 76 | 152 | NCT06143670 | Trial comparisons |
| Sensodyne Repair and Protect (Test Dentifrice) vs Colgate Cavity Protection (Negative Control Dentifrice): deaths from any cause | 0 of 65 | 0 of 65 | 130 | NCT04050722 | Trial comparisons |
| Sensodyne Repair and Protect (Test Dentifrice) vs Colgate Cavity Protection (Negative Control Dentifrice): serious adverse events | 0 of 65 | 0 of 65 | 130 | NCT04050722 | Trial comparisons |
| Experimental Treatment vs Placebo Control: serious adverse events | 0 of 60 | 0 of 60 | 120 | NCT00926328 | Trial comparisons |
| A - Fluoride Control vs B - Postive Control: serious adverse events | 0 of 55 | 0 of 50 | 105 | NCT00762619 | Trial comparisons |
| Experimental Test Stannous Fluoride Dentifrice vs Control Sodium Monofluorophosphate Dentifrice: deaths from any cause | 0 of 50 | 0 of 48 | 98 | NCT04123665 | Trial comparisons |
| Experimental Test Stannous Fluoride Dentifrice vs Control Sodium Monofluorophosphate Dentifrice: serious adverse events | 0 of 50 | 0 of 48 | 98 | NCT04123665 | Trial comparisons |
| Chlorhexidine (0.2%) vs Punica Granatum Pleniflora Mouth Rinse: serious adverse events | 0 of 36 | 0 of 38 | 74 | NCT02227485 | Trial comparisons |
| Negative Control Rinse vs Iocide Mouthrinse: serious adverse events | 0 of 34 | 0 of 33 | 67 | NCT01021007 | Trial comparisons |
| B- Active Comparator vs A -Placebo Comparator: serious adverse events | 0 of 22 | 0 of 22 | 44 | NCT00762515 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0002508/comparisons